Quiet Trim From Levin: O-I Glass Faces Bigger Questions
Institutional moves can quietly reshape a stock's risk and reward. This article looks at Levin's trim of O-I Glass an...
Determine whether a 6-month or 12-month fund is right for you by assessing income stability, essential expenses, and personal risk appetite.
15,911 articlesInstitutional moves can quietly reshape a stock's risk and reward. This article looks at Levin's trim of O-I Glass an...
A high-profile privacy battle shines a light on how personal finance and privacy intersect. Learn practical steps to ...
Schd’s $71.6 billion portfolio has posted a 20% year-to-date price gain alongside a 3.3% yield, underscoring the appe...
Andreessen Horowitz’s crypto arm is raising its fifth fund, aiming about $2 billion with a close planned for mid-2026...
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
A premium fitness brand attracts a substantial fund investment while its stock lags. This piece breaks down what it m...
A big new stake in Ryan Specialty Holdings hints at growing confidence from a niche investor. This article breaks dow...
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Cathie Wood and Ark Invest pulled cash from several holdings in a single session, sparking questions about risk, liqu...
Two popular U.S. dividend ETFs take different paths to income. This guide breaks down how SCHD and FDVV approach divi...
Income-focused investors are turning to monthly dividend ETFs yielding strong cash flow in 2026. Four funds stand out...
A new ETF focused on CTAs began trading this week, giving U.S. investors direct exposure to trend-following across mu...